The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the patent expiration in key regions has introduced considerable uncertainty . Investors are now facing the consequences of lower-